Reference no: EM132743776
Questions -
Q1. Pharmacia Sdn Bhd sells product A in Market 1. The following information relates to the markets available for product A.
|
Market 1
|
Market 2
|
Market 3
|
Volume per year
|
100,000 units
|
500,000 units
|
1,000,000 units
|
Sales Price
|
5 million
|
5.5 million
|
6 million
|
Transaction costs
|
0.1 million
|
0.15 million
|
0.2 million
|
Transportation costs
|
0.1 million
|
0.15 million
|
0.1 million
|
REQUIRED -
(a) Calculate the possible fair value for product A in Market 1, 2 and 3.
(b) Determine the principle market.
(c) Determine the most advantageous market.
(d) If Pharmacia Sdn Bhd is unable to sell in Market 3 given to some restrictions, calculate the fair value of product A.
Q2. The board of directors of Baktii Berhad, a public listed industrial company, are considering making an offer to purchase Dermawan Sdn Bhd, a small and unlisted companies operating in industrial sector. Baktii Bhd shall contine to use Dermawan Sdn Bhd as one of its branch producing the same industrial goods.
Summarised excerpt from the most recent 2017 Financial Position and Profit and Loss Statements for Baktii and Dermawan are shown below:
Baktii Berhad 2017 Dermawan Sdn Bhd 2017
RM million RM million '000 '000
Freehold property 33 460
Plant and Equipment 58 1,310
Inventories 29 330
Receivables 24 290
Cash 3 20
Less current liabilities (31) 25
(518) 122 116 1892
Financed by Ordinary shares, RM0.5 35
Ordinary shares, RM0.25 160
Reserves 43 964
Shareholders' funds 78 1124
Medium term bank loan 38 768
116 1892
The following are the amount of Profit after tax and dividend payment for the last 5 years for both companies:
Year Baktii Berhad Dermawan Sdn Bhd
Profit after Tax(mil) Dividend (mil) Profit after Tax (000) Dividend (000)
2012 14.30 9.01 143 85.0
2013 15.56 9.80 162 93.5
2014 16.93 10.67 151 93.5
2015 18.42 11.60 175 102.8
2016 20.04 12.62 183 113.1
Dermawan Sdn Bhd shares are owned by a small number of private individuals. Its managing director, who receives an annual salary of RM350,000, dominates the company. This amount is RM30,000 more than the average salary received by managing directors of similar companies. The managing director would be replaced if Baktii decided to purchase Dermawan Sdn Bhd.
The freehold property has not been revalued for several years and is believed to have a market value of RM800,000. The value of plant and equipment in the statement of Financial Position is thought to reflect replacement cost fairly, but its value if sold is not likely to exceed RM800,000. Approximately RM55,000 of the inventory is obsolete and could only be sold as scrap for RM5,000.
The ordinary shares of Baktii are currently trading at RM4.30 ex-div. A suitable cost of equity for Dermawan Sdn Bhd has been estimated at 15%. Both companies are subjected to corporation tax of 33%.
REQUIRED -
a) Estimate the value of Dermawan Sdn Bhd. at the end of 2015 using different methods of valuation as follows:
i) Net assets valuation.
ii) Dividend valuation model
iii) P/E or earnings valuation.
b) Advise the board of Baktii Bhd as to how much it should offer for Dermawan Sdn Bhd shares.